Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Interim Management Statement

17 Apr 2014 15:57

RNS Number : 1207F
Maven Income and Growth VCT 5 PLC
17 April 2014
 

 

Maven Income and Growth VCT 5 PLC (the Company)

 

Interim Management Statement - quarter ended 28 February 2014

 

This Interim Management Statement, for the quarter ended 28 February 2014, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 March 2014 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net Asset Value (NAV)1 of 40.30p per share at 28 February 2014, compared to 37.09p per share at 30 November 2013;

· NAV total return2 of 65.60p at 28 February 2014, compared to 62.39p at 30 November 2013; and

· Final dividend of 1.35p per share in respect of the year ended 30 November 2013, proposed for payment on 30 May 2014.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 28 February 2014. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 November 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 28 February 2014: a total of £1,348,175 was invested in six private companies, five of these companies were new investments and one was a follow-on investment; aggregate proceeds of £1,763,526 were realised from the disposal of nine AIM quoted investments against a total cost of £1,860,797; and a net £3,196,700 was invested in short-dated UK Government Securities. A total of £291,475 was realised from the disposal of unlisted equities and loan stock.

 

3.

Recent developments

 

Between 1 March 2014 and the date of this Statement: £724,429 was invested in four unlisted companies, two of these companies were new investments and two were follow-on investments; the disposal of shares in eight AIM quoted investments realised aggregate proceeds of £874,221 against cost of £471,611; also the disposal of shares in one private company realised proceeds of £368,000 against a cost of £400,000 and the sale of UK Government Securities realised £3,000,000 of proceeds against £2,998,020 of cost.

 

 

4.

Offer for subscription

 

Up to and including 5 April 2014, the Company had received valid applications to the value of £3.07 million pursuant to its Offer for Subscription (the Offer), which opened on 24 October 2013. All valid applications in respect of the 2013/14 tax year, representing the sum of £2.77 million, have been accepted in full. Pursuant to the Offer, and subsequent to an initial allotment of 4,346,689 shares on 3 February 2014, the Company issued and allotted a further 2,310,321 Ordinary Shares of 10 pence each on 5 April 2014. The Offer Price at which all of these shares were issued and allotted was 41.58p per Ordinary Share. As a result of these allotments the number of Ordinary Shares now in issue is 67,512,435. It is intended that a further allotment, in respect of the 2014/15 tax year, will take place by no later than 30 April 2014 and will, in part, utilise the over-allotment facility set out in the Prospectus for the Offer.

 

Other than as described above and changes in the value of investments quoted on regulated markets, the Board is not aware of any events during the period from 1 December 2013 to 28 February 2014, or in the period from 1 March 2014 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

 

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

17 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZDLFFZZFEBBE
Date   Source Headline
20th May 202610:20 amRNSAdmission of Further Securities to Trading
15th May 202610:10 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:39 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20264:10 pmRNSTransaction in Own Shares
28th Apr 20263:55 pmRNSResult of AGM
28th Apr 20261:35 pmRNSResult of AGM
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:30 amRNSAdmission of Further Securities to Trading
14th Apr 202611:11 amRNSIssue of Equity
8th Apr 20269:35 amRNSAdmission of Further Securities to Trading
27th Mar 20265:07 pmRNSOffer for Subscription - Fully Subscribed
25th Mar 202610:59 amRNSAdmission of Further Securities to Trading
25th Mar 20267:00 amRNSAnnual Financial Report
24th Mar 202612:13 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSUnaudited Net Asset Value
3rd Mar 20264:31 pmRNSTransaction in Own Shares - correction
27th Feb 20265:04 pmRNSTransaction in Own Shares
26th Feb 20264:53 pmRNSTransaction in Own Shares
26th Feb 20269:15 amRNSDividend Declaration
18th Feb 20265:01 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:11 amRNSDirector/PDMR Shareholding
17th Feb 202610:58 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:13 amRNSAdmission of Further Securities to Trading
16th Jan 20269:47 amRNSIssue of Equity
14th Jan 20262:44 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202511:15 amRNSDirector/PDMR Shareholding
16th Dec 202510:30 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:45 pmRNSResult of General Meeting
7th Oct 20254:15 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:11 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:17 pmRNSStatement re Dividend Investment Scheme
17th Jul 20253:21 pmRNSHalf-year Report
16th Jul 20255:33 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:50 pmRNSStatement re Unaudited NAV and Interim Dividend
14th May 20254:46 pmRNSTransaction in Own Shares
9th May 20259:59 amRNSIssue of Equity
6th May 202511:55 amRNSIssue of Equity
2nd May 20251:27 pmRNSUnaudited NAV - Dividend Investment Scheme
29th Apr 20253:20 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
15th Apr 20259:32 amRNSDirector/PDMR Shareholding
4th Apr 20256:22 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:14 pmRNSDirector/PDMR Shareholding
27th Mar 20251:09 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.